Rabeprazole and Hypophysitis - a phase IV clinical study of FDA data

Summary:

Hypophysitis is reported as a side effect among people who take Rabeprazole (rabeprazole sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Opdivo, and have High blood pressure.

The phase IV clinical study analyzes which people have Hypophysitis when taking Rabeprazole. It is created by eHealthMe based on reports of 31,196 people who have side effects when taking Rabeprazole from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Hypophysitis?

Hypophysitis (inflammation of the pituitary gland) is found to be associated with 153 drugs and 175 conditions by eHealthMe. Check the latest studies of Hypophysitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

31,196 people reported to have side effects when taking Rabeprazole.
Among them, 13 people (0.04%) have Hypophysitis.

Could Rabeprazole cause Hypophysitis?

Among these 13 people:

How long have people been on Rabeprazole when they have Hypophysitis? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Hypophysitis when taking Rabeprazole? *

  • female: 46.15 %
  • male: 53.85 %

What is the age of people who have Hypophysitis when taking Rabeprazole? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Rabeprazole? *

  1. Opdivo: 6 people, 46.15%
  2. Zyprexa: 3 people, 23.08%
  3. Symbicort: 3 people, 23.08%
  4. Sutent: 3 people, 23.08%
  5. Pyridoxine: 3 people, 23.08%
  6. Potassium Chloride: 3 people, 23.08%
  7. Lenvatinib: 3 people, 23.08%
  8. Rozerem: 2 people, 15.38%
  9. Keytruda: 2 people, 15.38%
  10. Belsomra: 2 people, 15.38%

What are other side effects people have besides Hypophysitis? *

  1. Primary Hypothyroidism (failure of the thyroid gland to produce or release thyroid hormones into the bloodstream): 6 people, 46.15%
  2. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 4 people, 30.77%
  3. Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
  5. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 3 people, 23.08%
  6. Colitis (inflammation of colon): 3 people, 23.08%
  7. Blood Corticotrophin Decreased: 3 people, 23.08%
  8. Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 3 people, 23.08%
  9. Guillain-Barre Syndrome (the body's immune system attacks its peripheral nervous system): 2 people, 15.38%
  10. Diarrhea: 2 people, 15.38%

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 30.77%
  2. High Blood Pressure: 4 people, 30.77%
  3. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 23.08%
  4. Endometrial Cancer: 3 people, 23.08%
  5. Stable Angina (a constant chest pain): 2 people, 15.38%
  6. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 15.38%
  7. Insomnia (sleeplessness): 2 people, 15.38%
  8. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 2 people, 15.38%
  9. Enlarged Prostate: 2 people, 15.38%
  10. Cardiac Failure: 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and have Hypophysitis?

- Check whether Hypophysitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rabeprazole:

Hypophysitis treatments and more:

How severe was Hypophysitis and when was it recovered:

Expand to all the drugs that have ingredients of rabeprazole sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypophysitis:

Browse all the conditions that are associated with Hypophysitis:


How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium (the active ingredients of Rabeprazole) and Rabeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: